Back

Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition

Mattia, Z.; Banfi, F.; Massimino, L.; Volpin, M.; Bellini, E.; Brusco, S.; Merelli, I.; Barone, C.; Bruni, M.; Bossini, L.; Lamparelli, L. A.; Pintado, L.; Spinelli, S.; Mologni, L.; Colasante, G.; Ungaro, F.; Cioni, J.-M.; Azzoni, E.; Piazza, R.; Montini, E.; Broccoli, V.; Sessa, A.

2022-09-13 developmental biology
10.1101/2022.09.12.507599 bioRxiv
Show abstract

Within the chromatin, distal elements interact with promoters to regulate specific transcriptional programs. Histone acetylation, interfering with the net charges of the nucleosomes, is a key player in this regulation. Here, we report that the onco-protein SET is a critical determinant for the levels of histone acetylation within enhancers. We disclose that conditions in which SET is accumulated, including the severe Schinzel-Giedion Syndrome (SGS), are characterized by a failure in the usage of the distal regulatory regions typically employed during fate commitment. This is accompanied by the usage of alternative enhancers leading to a massive rewiring of the distal control of the gene transcription. This represents a (mal)adaptive mechanism that, on one side, allows to achieve a certain degree of differentiation, while on the other affects the fine and corrected maturation of the cells. Thus, we propose the differential in cis-regulation as a contributing factor to the pathological basis of the SET-related disorders in humans, including SGS, neurodevelopmental disorders, myeloproliferative diseases, and cancer.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.